JD Supra12m
FDA Accepts U.S. Biologics License Application for AVT06, Alvotech and Teva’s Proposed Aflibercept Biosimilar
Alvotech and Teva Pharmaceuticals (“Teva”) announced that the U.S. Food and Drug Administration (FDA) has accepted for review ...
precisionmedicineonline54m
BMS Seeking FDA Approval for Opdivo-Yervoy in Frontline MSI-High, dMMR Advanced Colorectal Cancer
The firm submitted data from a Phase III study showing the combination improved outcomes compared to Opdivo and chemo alone.
Hunter Schafer ‘shocked’ her passport gender changed after Trump order
The 'Euphoria' actor said she was making the video not to 'fearmonger or create drama or receive consolation,' but to note ...
TALTZ’S Rapid Market Ascent Reflects Its Unparalleled Ability To Transform The Treatment Landscape For Autoimmune Diseases | Delveinsight
TALTZ (ixekizumab), an IL-17A inhibitor by Eli Lilly, has shown strong market growth driven by increasing adoption in psoriasis, psoriatic arthritis, ...
Photodynamic Therapies In Oncology Market Is Predicted To Exhibit Remarkable Growth During The Study Period (2020–2034) | Delveinsight
The market for PDTs in oncology is projected to experience substantial growth in the coming years. This growth is driven by a rising number of patien ...